Windtree Therapeutics announced new funding of up to $520 million, with 99% of the proceeds allocated for BNB acquisitions, indicating one of the boldest acquisition moves by a public biotech company in the cryptocurrency space. Windtree Biotech is doubling down on cryptocurrency with a new BNB plan. Windtree Therapeutics (NASDAQ: WINT) is strongly focused on digital assets,

$BNB

#bnb #ERA #wct #lagrange #elaouzi